功能性消化不良患者采用莫沙必利联合黛力新治疗的临床效果分析  

Clinical Analysis of Mosapride Combined with Dailixin Treatment in Patients with Functional Dyspepsia

作　　者：周甜[1] ZHOU Tian(Department of Gastroenterology,Xuzhou Central Hospital,Xuzhou,Jiangsu Province,221009 China)

机构地区：[1]徐州市中心医院消化内科

出　　处：《中外医疗》2019年第27期130-132,共3页China & Foreign Medical Treatment

摘　　要：目的研究并分析功能性消化不良患者采用莫沙必利联合黛力新治疗的临床效果。方法方便选取该院2017年3月—2018年3月收治的110例功能性消化不良患者作为研究对象,依据电脑随机方式将患者分为对照组和实验组,每组功能性消化不良患者55例,对照组功能性消化不良患者实行莫沙必利治疗,实验组功能性消化不良患者实行莫沙必利联合黛力新治疗,对比两组功能性消化不良患者治疗后治疗效果、不良反应率以及临床病症评分变化。结果治疗后,实验组功能性消化不良患者的治疗有效率为98.18%(54/55)高于对照组治疗有效率78.18%(43/55),比较差异有统计学意义(χ^2=7.856,P=0.000);两组患者治疗后不良反应率大致相同,比较差异无统计学意义(P>0.05);两组患者治疗前上腹痛、上腹胀、早饱、嗳气等临床病症评分大致相同,比较差异无统计学意义(P>0.05);治疗后,实验组功能性消化不良患者上腹痛、上腹胀、早饱、嗳气等临床病症评分低于对照组,比较差异有统计学意义(t=12.340,P=0.000)。结论莫沙必利联合黛力新治疗功能性消化不良具有良好治疗效果,能够帮助患者实现疾病治疗,具有极高治疗有效率,同时不良反应率低,且有助于改善患者临床病症评分,值得实施推广。Objective To study and analyze the clinical effects of mosapride combined with Dailixin in patients with functional dyspepsia.Methods Convenient selected a total of 110 patients with functional dyspepsia admitted to our hospital from March,2017 to March,2018 were enrolled.The patients were divided into the control group and the experimental group according to the computer randomized method.Each group had functional dyspepsia.There were 55 patients in each group.The patients with functional dyspepsia in the control group were treated with mosapride.The patients with functional dyspepsia in the experimental group were treated with mosapride combined with Dailixin,and the therapeutic effects of the two groups of patients with functional dyspepsia were compared,as well as adverse response rates and changes in clinical disease scores.Results After treatment,the effective rate of the patients with functional dyspepsia was 98.18%(54/55),which was higher than that of the control group 78.18%(43/55).The difference was statistically significant(χ^2=7.856,P=0.000);the adverse reaction rate of the two groups of patients after treatment was about the same,the difference was not statistically significant(P>0.05);the two groups of patients before treatment,upper abdominal pain,upper abdominal distension,early satiety,hernia and other clinical conditions scored roughly same,the difference was not statistically significant(P>0.05);after treatment,the experimental group of functional dyspepsia patients with upper abdominal pain,upper abdominal distension,early satiety,hernia and other clinical symptoms scores lower than the control group,the difference was statistically significant(t=12.340,P=0.000).Conclusion Mosapride combined with Dailixin has a good therapeutic effect on functional dyspepsia.It can help patients to achieve disease treatment,has extremely high therapeutic efficiency,and has low adverse reaction rate,and helps to improve the clinical disease score of patients.It is worth implementing promotion.

关 键 词：功能性消化不良 莫沙必利 黛力新 治疗效果 不良反应 

分 类 号：R57[医药卫生—消化系统]